SEC Comment Letter 0000000000-24-001197 to Aspire Biopharma Holdings, Inc. (ASBP)

Aspire Biopharma Holdings, Inc.
Date: Jan. 31, 2024 · CIK: 0001847345 · Accession: 0000000000-24-001197

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 001-41293

Date

January 31, 2024

Author

Howard Doss

Form

UPLOAD

Company

Aspire Biopharma Holdings, Inc.

Letter

United States securities and exchange commission logo January 31, 2024 Howard Doss Chief Financial Officer PowerUp Acquisition Corp. 188 Grand Street, Unit #195 New York, NY 10013 Re:PowerUp Acquisition Corp. Form 10-K for the year ended December 31, 2022 Filed March 21, 2023 File No. 001-41293 Dear Howard Doss: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Real Estate & Construction

Show Raw Text

United States securities and exchange commission logo
January 31, 2024
Howard Doss
Chief Financial Officer
PowerUp Acquisition Corp.
188 Grand Street, Unit #195
New York, NY 10013
Re:PowerUp Acquisition Corp.
Form 10-K for the year ended December 31, 2022
Filed March 21, 2023
File No. 001-41293
Dear Howard Doss:
            We have completed our review of your filing. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Real Estate & Construction

SecProbe.io